Désolé, cet article est seulement disponible en Anglais Américain.
Cliquez pour voir le graph
Cliquez pour voir la ligne de temps
Ligne de temps
Understanding viral attenuation for the rationalization of vaccine design
Nolwenn Jouvenet (PI)
Vaccination is one of the greatest successes of modern medicine. The first generation of viral vaccines relied on empiric attenuation by repeated passage in animals and/or cultured cells. A successful attenuation process eliminates virulence […]
February 2013- to date: Postdoctoral Researcher
Description: I’m working in the “Viral Genomics and Vaccination” Unit to delineate the innate immune mechanisms involved in the host response against Yellow fever virus and other viruses.
August 2015: Group Leader and WHO Consultant
I was employed for a month in a mission to fight the Ebola epidemic as Head of the Pasteur Institut Ebola Diagnosis Laboratory of Macenta, Guinea. I also contributed to the field work related to surveillance and response activities, under the Global Outbreak Alert and Response Network (GOARN) umbrella.
October 2008- October 2012: Ph.D. Candidate and Laboratory Demonstrator
Description: I concluded 4-year Ph.D. Programme in Immunology, which took place in The Institute of Immunology (NUI Maynooth, Ireland). The title of my Ph.D. thesis is: “Investigating the role of IRAK1 in Toll-like receptor (TLR) signalling pathways”. Alongside my Ph.D. research, I’ve been demonstrating Biology laboratory classes to BSc. students, helping and guiding them during practical sessions.
December 2007 – June 2008: Apprentice Pharmacist
Description: I carried out a 6-month practical training in an approved establishment under the supervision of a tutor pharmacist, in order to enter the Licence Examination, which was successfully passed within July 2008.
Name and address of employer: Pharmacy Dr. Esposito V., Rome, Italy.
October 2006 – October 2007: Research Associate
Description: The research for my Master’s thesis was conducted in the framework of a research apprenticeship in Sigma-Tau S.p.A.. The title of my thesis is: “Screening of active molecules modulating the pro-inflammatory pathway mediated by TLR/IL-1R activation”.
Name and address of employer: Sigma-Tau S.p.A, Pomezia, Italy.
October 2008- October 2012: Ph.D. in Immunology, NUIM, Maynooth, Ireland.
December 2007 – June 2008: Doctor of Pharmacy (Pharm.D.), Sapienza University of Rome and Pharmacy Dr. Esposito V., Rome, Italy.
November 2000 – November 2007: M.Sc. in Industrial Pharmacy (Chimica e Tecnologia Farmaceutiche), Sapienza University of Rome, Italy. Final mark: 110/110.
September 1995- July 2000: Diploma, Liceo Scientifico “Aristotele”, Roma, Italy. Final mark: 100/100 summa cum laude.
Mother tongue: Italian
Other languages: English (bilingual), French (basic working proficiency)
2015Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons, Sci Signal 2015 Mar;8(366):ra25.
2015HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells, Retrovirology 2015;12:2.
2013Identification of RNA partners of viral proteins in infected cells, RNA Biol 2013 Jun;10(6):944-56.